National Institute of Diabetes and Digestive and Kidney Diseases
North America, Maryland, United States, Bethesda
Description
National Institute of Diabetes and Digestive and Kidney Diseases is part of the United States National Institutes of Health.
Investor Profile
National Institute of Diabetes and Digestive and Kidney Diseases has backed more than 48 startups, with 6 new investments in the last 12 months alone. The firm has led 42 rounds, about 88% of its total and boasts 7 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Grant rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Led 6 rounds in the past year.
Stage Focus
- Grant (100%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Therapeutics
- Pharmaceutical
- Diabetes
- Medical Device
- Health Diagnostics
- Life Science
- Biopharma
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
